Volume 17, Issue 1 (2022) | American Journal of Pharmacology and Toxicology

Association of Remdesivir with Poor Clinical Outcomes in COVID-19-A Single Center Experience

Rajat Ranka — 2022-06-03

American Journal of Pharmacology and Toxicology, Published online: 3 June 2022; doi:10.3844/ajptsp.2022.1.8

The need for an antiviral against COVID-19 prompted clinical trials worldwide and based on initial promising trends, remdesivir was widely used, including in India (compassionate use). Subsequent tria...

Coenzyme Q10 Supplementation Effect on Systemic Diseases

Aya Jabbar Hussein — 2022-10-20

American Journal of Pharmacology and Toxicology, Published online: 20 October 2022; doi:10.3844/ajptsp.2022.9.26

This review paper aims to examine recent RandomizedClinical Trials (RCTs) and review articles evaluating the role of CoQ10 in themanagement of atherosclerosis, and coronary heart disease, with particu...

Drug Interactions Pharmacology: A Narrative Review

Lívia Maria Barbosa Neves — 2022-10-25

American Journal of Pharmacology and Toxicology, Published online: 25 October 2022; doi:10.3844/ajptsp.2022.27.36

Thesimultaneous prescription of multiple drugs used in therapeutic schemes canresult in drug interactions, with desirable or undesirable effects. Thus, theobjective of this study was to describe the m...

Drug Repositioning in Response to COVID-19 and other Challenging Diseases

Hyellavala Joseph Fomnya — 2022-11-28

American Journal of Pharmacology and Toxicology, Published online: 28 November 2022; doi:10.3844/ajptsp.2022.37.47

Coronavirus disease is a highly contagious infection that is majorly associated with upper respiratory tract illnesses. The World Health Organization (WHO) label the novel coronavirus disease COVID-19...